Providers: Drug Payments Aren't As Bad As Docs Expected... They're Worse

Why This Topic Matters

The article matters because it highlights how Medicare payment methodology, billing placement, and compliance enforcement can affect reimbursement and audit risk for provider organizations.

Article Sections

1. Medicare drug pricing and provider concerns

   Discusses updated Medicare drug pricing information and provider reactions to the payment amounts reported in the final rule. It also references CMS and GAO discussion about drug availability and acquisition concerns.

2. Drug administration billing guidance

   Summarizes CMS clarification about billing for drug administration services in different care settings. The section addresses general administration billing structure and how CMS framed the service relationship to physician care.

3. Incident-to billing court case

   Summarizes a federal appellate decision involving alleged Medicare billing errors in a clinic setting. The section covers the enforcement outcome and related compliance issues raised by the case.